POINT Biopharma Global Inc (PNT)
NCM · SPAC · CUSIP 730541109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PNT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Special Purpose Acquisition Company (SPAC)
CUSIP
730541109 (prev. 88339T103 )
Market Cap
Mid Cap · $698 Million
IPO
7/8/2020 · $10.00/share
Previous Symbol
RACA (changed 6/30/2021)
Previous Name
Therapeutics Acquisition Corp.
Business: POINT Biopharma Global Inc is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer.
Notes: We know of no homepage for this Company.

Company Contact

CEO
Joe McCann
CFO
Bill Demers
Headquarters
4850 West 78th Street, Indianapolis IN, 46268
Phone
647-812-2417
Investor Relations
Daniel Pearlstein · 647-812-2417 · investors@pointbiopharma.com
SEC EDGAR Filings
View filings »